Gene: TFR2
Official Full Name: transferrin receptor 2provided by HGNC
Gene Summary: This gene encodes a single-pass type II membrane protein, which is a member of the transferrin receptor-like family. This protein mediates cellular uptake of transferrin-bound iron, and may be involved in iron metabolism, hepatocyte function and erythrocyte differentiation. Mutations in this gene have been associated with hereditary hemochromatosis type III. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35021 | TFR2 Knockout cell line (HeLa) | Human | TFR2 | 1:3~1:6 | Negative | Online Inquiry |
KO35022 | TFR2 Knockout cell line (HCT 116) | Human | TFR2 | 1:2~1:4 | Negative | Online Inquiry |
KO35023 | TFR2 Knockout cell line (A549) | Human | TFR2 | 1:3~1:4 | Negative | Online Inquiry |
TFR2 Gene Knockout Cell Lines are advanced biological tools specifically engineered to lack the Transferrin Receptor 2 (TFR2) gene, which plays a crucial role in iron homeostasis and regulation in mammalian cells. These cell lines facilitate in-depth exploration of iron metabolism and related pathologies, such as hereditary hemochromatosis and other iron overload disorders. This knockout model provides a unique platform for researchers to study the functional consequences of TFR2 deficiency, allowing for the assessment of cellular responses to altered iron availability and the identification of potential therapeutic targets.
The key mechanisms of action for TFR2 knockout cell lines lie in their inability to effectively mediate iron uptake through transferrin and their altered expression of iron-regulatory proteins. By utilizing these cell lines, scientists can observe changes in iron signaling pathways, cellular growth, and differentiation, as well as the impact on overall cellular physiology. This makes them an essential asset for investigations into diseases characterized by dysregulated iron metabolism.
In research and clinical applications, TFR2 Gene Knockout Cell Lines stand out for their contributions to our understanding of iron-related diseases. They allow for high-throughput screening of compounds that may reverse or ameliorate iron overload conditions, making them invaluable in drug development and the field of precision medicine.
Compared to traditional models, our TFR2 knockout cell lines offer specific advantages, including reliability in reproducibility and precise genetic targeting that enables clear interpretation of results. They are also suitable for various experimental approaches, from basic research to more complex therapeutic interventions, thus appealing to a broad spectrum of scientists and clinicians.
The expertise of our company in developing high-quality biological products ensures that these knockout cell lines are not only validated rigorously but also supported by a library of resources and guidance for users. By choosing our TFR2 Gene Knockout Cell Lines, researchers can leverage state-of-the-art tools that enhance scientific inquiry and advance the understanding of iron metabolism in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.